The specifics of emotional dysregulation in women with various types of irritable bowel syndrome

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND. To this day, relatively little is known about the specifics and mechanisms by which psychological factors, such as a general tendency to anger and the style of expressing anger, can be associated with pro-inflammatory processes and visceral hypersensitivity, which contribute to the appearance of signs of irritable bowel syndrome and lead to its refractory course.

AIM. The purpose of the work. to identify the specifics of differences in the presence and severity of depression, anxiety, anger expression and satisfaction with the quality of life in women (average age 39.2±10.6) with refractory IBS of constipated, diarrheal and mixed types (duration of the disease 33.8±48.1 months), based on the hypothesis that women with different types of IBS may have different styles of expressing negative emotions (for example, anger) and ways of controlling behavior.

MATERIAL AND METHODS. PHQ-15 — Patient Health Questionnaire-15; GAD-7 — General Anxiety Disorder-7; PHQ-9 — Patient Health Questionnaire-9; IBS-QOL — Irritable Bowel Syndrome Quality of Life; STAXI — State–Trait Anger Expression Inventory.

RESULTS. Correlations between subtypes of IBS and negative aspects of the emotional sphere are observed and it is shown that subtypes of IBS-C and IBS-D demonstrate affective profiles characterized by a higher level of anxiety, depression and changes in the expression of anger with difficulties of expression both verbally and nonverbally. All types are characterized by autoaggression, suppression of anger, but these aspects are more pronounced in IBS-D and IBS-C. There is intense control of anger expression. With IBS-C and IBS-M, there is greater control over the expression of anger externally than with IBS-D. Women with IBS-C have more pronounced indicators of anger as a mental state. There are difficulties in verbal expression of anger, hetero- and autoaggression. Anger is a trait of character and is included in the structure of temperament. Women with IBS-D have pronounced indicators of anger as a reaction to a current life event, autoaggression, anger control inside. The level of affect somatization, the presence and severity of generalized anxiety disorder, depression, changes in life satisfaction are among the predictors that determine both the level of anger and the ways of its expression.

CONCLUSION. Intestinal motility can be considered as an indicator of behavior control, as an indicator of the regulatory function of the patient, the intensity of affective involvement in a particular situation. Changes in the cognitive, emotional and executive components of the mental organization play only a significant role in the refractory course of IBS.

Full Text

Restricted Access

About the authors

Aleksey I. Melehin

P.A. Stolypin Humanitarian Institute

Author for correspondence.
Email: clinmelehin@yandex.ru
ORCID iD: 0000-0001-5633-7639
SPIN-code: 6982-1468

Cand. Sci. (Psichol.), Associate Professor

Russian Federation, 107076, Moscow, Bukhvostova str., 1st, 12/11, bldg. 20.

References

  1. Ford AC. Commentary: estimating the prevalence of IBS globally — past, present and future. Aliment Pharmacol Ther. 2020;51(2):198–199. doi: 10.1111/apt.15508.
  2. Kim YS, Kim N. Sex-gender differences in irritable bowel syndrome. J Neurogastroenterol Motil. 2018;24(2):544–558. doi: 10.5056/jnm18082.
  3. Stengel A, Gourcerol G, Taché Y. Editorial: Neurogastroenterology — focus on the gut-brain axis. Front Psychiatry. 2021;4(12):65–93. doi: 10.3389/fpsyt.2021.653910.
  4. Eijsbouts C, Zheng T, Kennedy NA. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. Nat Genet. 2021;53(2):1543–1552. doi: 10.1038/s41588-021-00950-8.
  5. O’Mahony SM, Clarke G, Dinan TG. Irritable bowel syndrome and stress-related psychiatric co-morbidities: Focus on early life stress. Handb Exp Pharmacol. 2017;239(4):219–246. doi: 10.1007/164_2016_128.
  6. Melehin AI. Expositional cognitive-behavioral psychotherapy in the treatment of disorders of intestinal-brain interaction. Neurodynamics. Journal of Clinical Psychology and Psychiatry. 2020;2(1):20–41. (In Russ.)
  7. Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Experimental and Therapeutic Medicine. 2013;6(2):93–96. doi: 10.3892/etm.2013.1101.
  8. Muscatello MR, Bruno A, Mento C. Personality traits and emotional patterns in irritable bowel syndrome. World J Gastroenterol. 2016;22(28):6402–6415. doi: 10.3748/wjg.v22.i28.6402.
  9. Farnam A, Somi MH, Sarami F. Personality factors and profiles in variants of irritable bowel syndrome. World Journal of Gastroenterology, 2007;13(4):6414–6418. doi: 10.3748/wjg.v13.i47.6414.
  10. Melehin AI. The role of gastrointestinal specific anxiety and alexithymia as predictors of the severity of irritable bowel syndrome in women. Neurological Bulletin. 2021;53(1):34–41. (In Russ.)
  11. McKinnon AC, Van Oudenhove L, Tack J. The association of personality, appraisal, catastrophising and vigilance with gastrointestinal symptom-specific anxiety. Journal of Health Psychology. 2015;20(1):456–465. doi: 10.1177/1359105313503027.
  12. Adams LM, Turk DC. Psychosocial factors and central sensitivity syndromes. Curr Rheumatol Rev. 2015;11(4):96–108. doi: 10.2174/1573397111666150619095330.
  13. Muscatello MR, Bruno A, Scimeca G. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World Journal of Gastroenterology. 2014;20(24):7570–7586. doi: 10.3748/wjg.v20.i24.7570.
  14. Melehin AI, Kucheryavy YuA. The role of the deficit of the mental model (theory of mind) in the development and maintenance of gastrointestinal disorders. In: The human face in the context of nature, technology and culture. Moscow: Kogito-Center, 2021. P. 89–116. (In Russ.)
  15. David L, Fadgyas Stanculete M, Bolba AR. Coping strategies and irritable bowel syndrome: A systematic review. J Gastrointestin Liver Dis. 2021;8(1):19–32. doi: 10.15403/jgld-3937.
  16. Burns JW, Bruehl S, Chont M. Anger regulation style, anger arousal and acute pain sensitivity: evidence for an endogenous opioid triggering model. J Behav Med. 2014;37(1):642–653. doi: 10.1007/s10865-013-9511-z.
  17. Agazzi A, De Ponti F, De Giorgio R. Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders. Dig Liver Dis. 2003;35(3):590–595. doi: 10.1016/s1590-8658(03)00277-9.
  18. Stasi C, Bellini M, Bassotti G, Blandizzi C, Milani S. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Techniques in Coloproctology. 2014;18(1):613–621. doi: 10.1007/s10151-013-1106-8.
  19. Guthrie E, Creed F, Fernandes L, Ratcliffe J. Cluster analysis of symptoms and health seeking behaviour differentiates subgroups of patients with severe irritable bowel syndrome. Gut. 2003;52(3):1616–1622. doi: 10.1136/gut.52.11.1616.
  20. De Medeiros MT, Carvalho AF, de Oliveira Lima. Impact of depressive symptoms on visceral sensitivity among patients with different subtypes of irritable bowel syndrome. The Journal of Nervous and Mental Disease. 2008;196(10):711–714. doi: 10.1097/NMD.0b013e318183f896.
  21. Rey de Castro NG, Miller V, Carruthers HR, Whorwell PJ. Irritable bowel syndrome: a comparison of subtypes. Journal of Gastroenterology and Hepatology. 2015;30(1):279–285. doi: 10.1111/jgh.12704.
  22. Muscatello MR, Bruno A, Pandolfo G. Depression, anxiety and anger in subtypes of irritable bowel syndrome patients. J Clin Psychol Med Settings. 2010;17(1):64–70. doi: 10.1007/s10880-009-9182-7.
  23. Goodoory VC, Mikocka-Walus A, Yiannakou Y. Impact of psychological comorbidity on the prognosis of irritable bowel syndrome. Am J Gastroenterol. 2021;116(7):1485–1494.
  24. Blomhoff S, Signe Spetalen MD, Morten B. Intestinal reactivity to words with emotional content and brain information processing in irritable bowel syndrome. Dig Dis Sci 2000;45(2):1160–1165. doi: 10.1023/a:1005502119461.
  25. Greenwood KA, Thurston R, Rumble M. Anger and persistent pain: current status and future directions. Pain. 2003;103(4):1–5. doi: 10.1016/s0304-3959(03)00132-5.
  26. Sergienko EA. Mental development with the positions of a system-subjective approach. M.: Institute of Psychology of the Russian Academy of Sciences, 2021. 279 p. (In Russ.)
  27. Eriksson EM, Andrén KI, Eriksson HT, Kurlberg GK. Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers. The World Journal of Gastroenterology, 2008;14(2):4889–4896. doi: 10.3748/wjg.14.4889.
  28. Cho HS, Park JM. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut and Liver. 2011;5(1):29–36. doi: 10.5009/gnl.2011.5.1.29.
  29. Guthrie E, Creed F, Fernandes L. Cluster analysis of symptoms and health seeking behaviour differentiates subgroups of patients with severe irritable bowel syndrome. Gut. 2003;52(1):1616–1622. doi: 10.1136/gut.52.11.1616.
  30. Beesley H, Rhodes J, Salmon P. Anger and childhood sexual abuse are independently associated with irritable bowel syndrome. The British Journal of Health Psychology. 2010;15(3):389–399. doi: 10.1348/135910709X466496.
  31. Zoccali R, Muscatello MR, Bruno A. Anger and ego-defence mechanisms in non-psychiatric patients with irritable bowel syndrome. Dig Liver Dis. 2006;38(3):195–200. doi: 10.1016/j.dld.2005.10.028.
  32. Deschênes SS, Dugas MJ, Fracalanza K. The role of anger in generalized anxiety disorder. Cognitive Behaviour Therapy, 2012;4(1):261–271. doi: 10.1080/16506073.2012.666564.
  33. Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. The Journal of Abnormal Psychology, 1998;107(3):179–192. doi: 10.1037//0021-843x.107.2.179.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1

Download (399KB)
3. Fig. 2

Download (287KB)
4. Fig. 3

Download (393KB)
5. Fig. 4

Download (146KB)

Copyright (c) 2022 Melehin A.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 75562 от 12 апреля 2019 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies